Comparison of Anthropometric Parameters and Cardiometabolic Risk Factors Among Subjects With Overweight and Obesity
- Conditions
- Obesity
- Registration Number
- NCT04318288
- Lead Sponsor
- Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
- Brief Summary
The study was aimed at comparing four different anthropometric parameters to cardiometabolic risk factors in overweight and obese subjects (Body Mass Index (BMI)≥25)
- Detailed Description
the present study was focused to compare the level of statistical association among four different anthropometric parameters, body mass index (BMI), waist circumference (WC), waist to height ratio (WHtR) and neck circumference (NC) and the cardiovascular (CV) risk factors most commonly evaluated in the clinical practice such as systolic and diastolic blood pressure, and fasting glucose, lipid (triglycerides, total, High-density lipoprotein (HDL) and Low-density lipoprotein (LDL) cholesterol), insulin, Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), uric acid, 25-hydroxyvitamin D (25(OH)D), c-reactive protein (CRP), white blood cells and platelet number in a population of 1214 apparently healthy subjects with overweight and obesity subjects
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1214
- Overweight or obesity (BMI> 25 Kg/m2)
- Any kind of drug
- Hypertension
- Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism, etc.),
- Chronic inflammatory diseases
- Renal failure
- Liver failure
- Angina pectoris
- Myocardial infarction and heart failure
- Genetic heart diseases
- Thrombocytopenias
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method neck circumference baseline neck circumference (NC) (expressed in cm)
waist circumference baseline waist circumference (WC) (expressed in cm)
Body mass index baseline Body mass index (BMI) (expressed in kg/m\^2)
waist to height ratio baseline waist to height ratio (WHtR)
- Secondary Outcome Measures
Name Time Method Triglyceride baseline Triglyceride (expressed in mg/dL) concentration in serum
Homeostasis model assessment: insulin resistance baseline Homeostasis model assessment: insulin resistance index (HOMA-IR)
Platelets baseline Platelets (expressed in 10\^3/µL) concentration in serum
Blood pressure baseline blood pressure (BP) expressed in mmHg
Intima-media thickness baseline Intima-media thickness (IMT) (expressed in mm)
Total Cholesterol baseline Total Cholesterol (expressed in mg/dL) concentration in serum
fasting blood glucose baseline fasting blood glucose (FBG) (expressed in mg/dL) concentration in serum
Insulin baseline Insulin (expressed in mg/dL) concentration in serum
Vitamin D baseline Vitamin D (expressed in ng/dL) concentration in serum
C-reactive Protein baseline C-reactive Protein (CRP) (expressed in mg/dL)
HDL Cholesterol baseline HDL Cholesterol (expressed in mg/dL) concentration in serum
LDL Cholesterol baseline LDL Cholesterol (expressed in mg/dL) concentration in serum
white blood cells baseline white blood cells (WBC) (expressed in 10\^3/µL) concentration in serum
Trial Locations
- Locations (1)
National Institute of Gastroenterology IRCCS S. de Bellis
🇮🇹Castellana Grotte, Bari, Italy